Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Kidney & Blood Pressure Research|December 23, 2014
IgA nephropathy in Czech patients--are we able reliably predict the outcome?Dita Maixnerova, Michaela Neprasova, Jelena Skibova, et al.
Plos One|February 23, 2019
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progressionDita Maixnerova, Chunyan Ling, Stacy Hall, et al.
Plos One|July 13, 2019
Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progressionDita Maixnerova, Chunyan Ling, Stacy Hall, et al.
Clinical Kidney Journal|September 29, 2015
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN studyJorge Rojas-Rivera, Gema Fernández-Juárez, Alberto Ortiz, et al.
Journal of the American Society of Nephrology : JASN|February 14, 2015
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA StudyVladimir Tesar, Stéphan Troyanov, Shubha Bellur, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 24, 2020
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemicHans-Joachim Anders, Annette Bruchfeld, Gema Maria Fernandez Juarez, et al.
Renal Failure|September 13, 2005
Silica and asbestos exposure in ANCA-associated vasculitis with pulmonary involvementZuzana Rihova, Dita Maixnerova, Eva Jancova, et al.
Arthritis Research & Therapy|December 26, 2015
Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-upSatu Sinikka Pesickova, Romana Rysava, Martin Lenicek, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 11, 2021
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseasesAndreas Kronbichler, Hans-Joachim Anders, Gema Maria Fernandez-Juárez, et al.
Journal of Nephrology|September 7, 2019
Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?Hana Ciferska, Eva Honsova, Alena Lodererova, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Kidney & Blood Pressure Research|December 23, 2014
IgA nephropathy in Czech patients--are we able reliably predict the outcome?Dita Maixnerova, Michaela Neprasova, Jelena Skibova, et al.
Plos One|February 23, 2019
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progressionDita Maixnerova, Chunyan Ling, Stacy Hall, et al.
Plos One|July 13, 2019
Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progressionDita Maixnerova, Chunyan Ling, Stacy Hall, et al.
Clinical Kidney Journal|September 29, 2015
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN studyJorge Rojas-Rivera, Gema Fernández-Juárez, Alberto Ortiz, et al.
Journal of the American Society of Nephrology : JASN|February 14, 2015
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA StudyVladimir Tesar, Stéphan Troyanov, Shubha Bellur, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 24, 2020
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemicHans-Joachim Anders, Annette Bruchfeld, Gema Maria Fernandez Juarez, et al.
Renal Failure|September 13, 2005
Silica and asbestos exposure in ANCA-associated vasculitis with pulmonary involvementZuzana Rihova, Dita Maixnerova, Eva Jancova, et al.
Arthritis Research & Therapy|December 26, 2015
Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-upSatu Sinikka Pesickova, Romana Rysava, Martin Lenicek, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 11, 2021
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseasesAndreas Kronbichler, Hans-Joachim Anders, Gema Maria Fernandez-Juárez, et al.
Journal of Nephrology|September 7, 2019
Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?Hana Ciferska, Eva Honsova, Alena Lodererova, et al.
Pageof 20